What it is claimed to help
These are the uses attached to Kisspeptin-10 in research, clinical practice, or marketing. Listing a claim is not endorsing it — tap any of them to see every other compound carrying the same claim.
What the human evidence actually is
Randomised controlled human trials exist. Not necessarily approved, and not necessarily positive.
Better than most. Imperial College London has run randomised, placebo-controlled crossover trials of kisspeptin in men and women with low sexual desire, reporting enhanced brain responses to sexual stimuli and improved sexual function measures. Kisspeptin has also been used as an IVF trigger in clinical studies with a lower risk of ovarian hyperstimulation than hCG. Small trials, real methodology, no approval.
How it is supposed to work
Acts on KISS1R in the hypothalamus to trigger GnRH release — the upstream switch of the entire reproductive axis.
Safety
Well tolerated in trials; half-life is minutes, so exposure is brief. Chronic use is unstudied and continuous stimulation of this axis can downregulate it.
Storage and handling
Lyophilised peptide is generally stored at 2–8 °C, or below −20 °C for long-term storage. Reconstituted in bacteriostatic water (0.9% benzyl alcohol) a solution is typically treated as usable for about 28 days refrigerated, versus roughly 24 hours for plain sterile water, which has no preservative. Add the water slowly down the vial wall and swirl — never shake, which shears peptide chains and foams the solution.
Whatever number a protocol or a prescriber gave you, converting it into syringe units is where a misplaced decimal becomes a tenfold error. Our calculators do that conversion and nothing else — they never invent a dose.
Open the calculatorsSources
- Comninos AN et al. Kisspeptin and sexual brain processing, JCI 2017 / JAMA Netw Open 2022
- Abbara A et al. Kisspeptin as an IVF trigger, JCEM
Verified against primary sources on 27 August 2026. Regulatory status in this field changes several times a year. See How We Rate Evidence.